To the Editor:

We report 2 transient renal tubular syndromes associated with coronavirus disease 2019 (COVID-19).

A 47-year-old patient in a neurorehabilitation unit was diagnosed with COVID-19 following onset of respiratory symptoms and pyrexia, confirmed by reverse transcriptase polymerase chain reaction. Ten days later, he developed hypernatremia with an acute kidney injury. He was exclusively fed by percutaneous endoscopic gastrostomy tube.

Investigations ([Table 1](#tbl1){ref-type="table"} ) supported a diagnosis of nephrogenic diabetes insipidus. He was managed with increased enteral water intake via the percutaneous endoscopic gastrostomy and intravenous 5% dextrose over 24 hours. Biochemistry improved progressively, with serum sodium renal function returning to baseline by day 23.Table 1Serum and urine biochemistryPatient 1Patient 2Age, yr4752GenderMaleFemalePast medical historyTraumatic head injury 2018, PEG-fedDiabetic nephropathy, kidney/pancreas transplant 2011Drug therapyMeropenemTacrolimus, mycophenolate (suspended), meropenemDate of COVID-19 diagnosisApril 3, 2020March 26, 2020Onset of syndrome, days after COVID diagnosis103Resolution of syndrome, d2118Serum sodium, mmol/l152138Serum potassium, mmol/l3.62.9Serum creatinine, μmol/l15490Baseline serum creatinine, μmol/l6062Serum bicarbonate, mmol/l304Serum corrected calcium, mmol/l2.562.41Serum phosphate, mmol/l1.830.18Serum magnesium, mmol/l1.030.56Serum osmolality, mosmol/l321NDCRP, mg/l74100Urinary FE~PO4~, %ND70Urinary retinol binding protein/creatinine ratioND1540Urinary osmolality, mosmol/l264ND[^1]

A 52-year-old woman with diabetic nephropathy and a kidney-pancreas transplant was recovering from a below-knee amputation. She developed fever and a cough; reverse transcriptase polymerase chain reaction confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Three days later, she developed a severe metabolic acidosis associated with profound hypophosphatemia, hyperphosphaturia, and low molecular weight proteinuria, diagnostic of the renal Fanconi syndrome ([Table 1](#tbl1){ref-type="table"}). She required aggressive i.v. potassium, bicarbonate, and phosphate supplementation; she was weaned off all supplementation by day 18.

Kidney disease is widely recognized in COVID-19; there is evidence of direct viral invasion of the tubular epithelium.[@bib1] ^,^ [@bib2] Angiotensin-converting enzyme 2 (ACE2), the ligand for viral cell invasion, is expressed on both proximal and distal tubular cells.[@bib3] The first patient had a distal lesion (nephrogenic diabetes insipidus); the second had proximal tubular dysfunction.

These renal tubular syndromes support a direct toxic effect of the virus on the tubular epithelium. The prevalence and consequences of tubular dysfunction in COVID-19 is worthy of further study.

[^1]: CRP, C-reactive protein; ND, not done; PEG, percutaneous endoscopic gastrostomy.
